News
3rd October 2019 - OC-Sensor User Testimonials
Mast Group Ltd would like to thank OC-Sensor Users for providing feedback
Read more...
3rd October 2019 - OC-Sensor at IBMS Congress 2019
Mast Group Ltd had two stands at IBMS Congress 2019; one in Hall 4 focused on Microbiology products and another located in the registration area dedicated entirely to FIT.
Read more...
3rd October 2019 - Meet the FIT Technical Team
Mast Group Ltd have a dedicated FIT team based at Mast Headquarters in Bootle, Merseyside. The FIT team provides technical support to Mast account managers and customers pre and post sales.
Find out more...
24th July 2019 - Audit of FIT Poster from Luton and Dunstable University Hospital NHS Foundation Trust
Luton and Dunstable University Hospital NHS Foundation Trust have published a poster auditing Faecal Immunochemical Tests in a group of primary care symptomatic patients...
Read more...
15th April 2019 - Norfolk & Norwich University Hospital Interview
Norfolk & Norwich University Hospital (NNUH) Biochemistry Department is a hub laboratory closely aligned with our spoke laboratories at James Paget University Hospital and Queen Elizabeth Hospital, Kings Lynn.
Read more...
15th April 2019 - Level 3 Control - How low can you go?
OC-Sensor is routinely employed by Bowel Cancer Screening Programs worldwide to quantify very small amounts of haemoglobin in stool samples.
Read more...
20th June 2018 - Getting FIT in Nottingham
Nottingham University Hospitals Trust (NUHT) is continuing a long and distinguished history of scientific and service enhancements in the field for colorectal cancer, by offering an accredited reference service for FIT in symptomatic patients.
Read more...
8th November 2017 - Royal Preston Hospital Adopts OC-Sensor
The Royal Preston Hospital, Lancashire, has adopted OC-Sensor Faecal Immunochemical Test (FIT) into their Clinical Pathology services to provide a fast, accurate method for the diagnosis of colorectal diseases.
Read more...
1st November 2017: Increased uptake rates for OC-Sensor in Spain
Basque country recently presented a poster, displaying exceptional uptake rates in the 4th consecutive round of screening; at the 2017 International Cancer Screening Network (ICSN). The poster demonstrates an overall increase in participation of men from 63.7% to 71.9% and 69.1% to 76% in women, from the 1st round to the 4th round, respectively. The importance of the first participation is demonstrated as key to the successive increase in uptake from 66.5% to 74.1%.
Read more...
